NO20021402L - Stabil kalsitriolopplösning for pakking i ampuller - Google Patents

Stabil kalsitriolopplösning for pakking i ampuller

Info

Publication number
NO20021402L
NO20021402L NO20021402A NO20021402A NO20021402L NO 20021402 L NO20021402 L NO 20021402L NO 20021402 A NO20021402 A NO 20021402A NO 20021402 A NO20021402 A NO 20021402A NO 20021402 L NO20021402 L NO 20021402L
Authority
NO
Norway
Prior art keywords
ampoules
packing
stable
solution
calcitriol solution
Prior art date
Application number
NO20021402A
Other languages
English (en)
Other versions
NO20021402D0 (no
Inventor
Edward C Shinal
Original Assignee
Aai Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aai Pharma Inc filed Critical Aai Pharma Inc
Publication of NO20021402D0 publication Critical patent/NO20021402D0/no
Publication of NO20021402L publication Critical patent/NO20021402L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

Foreliggende oppfinnelse tilveiebringer en terapeutisk kalsitrioloppløsning som er egnet for pakking i farmasøytiske medisinglass og produserer misfarging av antioksidantkomponenten i oppløsningen.
NO20021402A 1999-09-29 2002-03-20 Stabil kalsitriolopplösning for pakking i ampuller NO20021402L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/408,970 US6211169B1 (en) 1999-09-29 1999-09-29 Stable calcitriol solution for packaging into vials
PCT/US2000/026417 WO2001022998A1 (en) 1999-09-29 2000-09-26 Stable calcitriol solution for packaging in vials

Publications (2)

Publication Number Publication Date
NO20021402D0 NO20021402D0 (no) 2002-03-20
NO20021402L true NO20021402L (no) 2002-03-20

Family

ID=23618517

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021402A NO20021402L (no) 1999-09-29 2002-03-20 Stabil kalsitriolopplösning for pakking i ampuller

Country Status (12)

Country Link
US (1) US6211169B1 (no)
EP (1) EP1216057B1 (no)
JP (1) JP2003510293A (no)
AT (1) ATE253940T1 (no)
AU (1) AU7616200A (no)
CA (1) CA2388438A1 (no)
DE (1) DE60006558T2 (no)
ES (1) ES2204692T3 (no)
MX (1) MXPA02003162A (no)
NO (1) NO20021402L (no)
PT (1) PT1216057E (no)
WO (1) WO2001022998A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030043931A (ko) * 2000-09-18 2003-06-02 에프. 에이취. 펄딩 앤드 컴파니 리미티드 디포스포네이트 용액
BR0214679A (pt) * 2001-12-03 2004-12-14 Novacea Inc Composições farmacêuticas compreendendo compostos a base de vitamina d ativa
US20040053895A1 (en) * 2002-09-18 2004-03-18 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US20040058895A1 (en) * 2002-09-18 2004-03-25 Bone Care International, Inc. Multi-use vessels for vitamin D formulations
US7148211B2 (en) * 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20050026877A1 (en) * 2002-12-03 2005-02-03 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
CA2521221A1 (en) * 2003-04-02 2004-10-14 Genix Therapeutics, Inc. Method for the treatment of prostate cancer
US20050020546A1 (en) * 2003-06-11 2005-01-27 Novacea, Inc. Pharmaceutical compositions comprising active vitamin D compounds
PL2601105T3 (pl) * 2010-08-06 2018-03-30 Hospira Australia Pty Ltd Sposób i system przygotowania fiolki
KR101946790B1 (ko) 2011-03-04 2019-02-13 그뤼넨탈 게엠베하 경구 투여를 위한 타펜타돌의 수성 약제학적 제형
WO2013114003A1 (fr) * 2012-01-30 2013-08-08 Laboratoires Urgo Procede de preparation d'un produit sirupeux comprenant des vitamines
WO2015119183A1 (ja) * 2014-02-05 2015-08-13 協和発酵キリン株式会社 活性型ビタミンｄ３またはその誘導体を含有する液剤
EP3273953B1 (en) 2015-03-27 2019-01-02 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
CN109996533A (zh) 2016-09-23 2019-07-09 格吕伦塔尔有限公司 用于肠胃外施用他喷他多的稳定制剂
CN116077432B (zh) * 2023-02-21 2023-09-08 正大制药（青岛）有限公司 一种骨化三醇口服溶液及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4308264A (en) * 1981-01-28 1981-12-29 Abbott Laboratories Stabilized, dilute aqueous preparation of 1α,25-dihydroxycholecalciferol for neonatal administration
US4420092A (en) 1982-09-01 1983-12-13 Mpl Inc. Tamper-resistant pharmaceutical vial and cap assembly
JP2545540B2 (ja) * 1987-05-29 1996-10-23 株式会社 大協精工 両面ラミネ−トゴム栓
US5230429A (en) 1990-12-13 1993-07-27 Etheredge Iii Robert W Tamper-evident injectable drug vial
JPH05238936A (ja) * 1992-02-27 1993-09-17 Dainippon Pharmaceut Co Ltd カルシトリオールの水性液剤
WO1996036340A1 (en) 1995-05-19 1996-11-21 Abbott Laboratories STABLE AQUEOUS FORMULATIONS OF 1α,25-DIHYDROXYCHOLECALCIFEROL FOR PARENTERAL ADMINISTRATION
US6051567A (en) * 1999-08-02 2000-04-18 Abbott Laboratories Low oxygen content compositions of 1α, 25-dihydroxycholecalciferol

Also Published As

Publication number Publication date
EP1216057B1 (en) 2003-11-12
EP1216057A1 (en) 2002-06-26
ATE253940T1 (de) 2003-11-15
DE60006558D1 (de) 2003-12-18
US6211169B1 (en) 2001-04-03
JP2003510293A (ja) 2003-03-18
DE60006558T2 (de) 2004-05-13
WO2001022998A1 (en) 2001-04-05
AU7616200A (en) 2001-04-30
NO20021402D0 (no) 2002-03-20
CA2388438A1 (en) 2001-04-05
PT1216057E (pt) 2004-04-30
MXPA02003162A (es) 2003-08-20
ES2204692T3 (es) 2004-05-01

Similar Documents

Publication Publication Date Title
NO20021402D0 (no) Stabil kalsitriolopplösning for pakking i ampuller
DE60025482D1 (de) Spritzgegossener stopfen für arzneimittelbehälter
CY1113078T1 (el) Συνθεση πολυσθενους εμβολιου
SE9904505D0 (sv) Novel compounds
IS1564B (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
AU560757B2 (en) Pharmaceutical compositions containing 3-hydroxybutanoic acid or a salt derived from this acid, and compounds derived from 3-hydroxybutanoic acid which can be used as medicaments
DK401089D0 (da) Farmaceutiske kombinationspraeparater til anvendelse som antineoplastiske laegemidler
AR033423A1 (es) Sales farmaceuticas constituidas de una sustancia activa farmaceutica y al menos un edulcorante, medicamentos que contienen estas sales y uso de estas sales para la preparacion de medicamentos
HN2003000407A (es) Nuevos derivados de fluoroglicosisdos aromaticos, medicamentos que contienen estos compuestos y sus usos.
ES2098140T3 (es) Liosferas que contienen gonadotropina.
BR0210139A (pt) Composições farmacêuticas
AR025052A1 (es) Derivados de 2-dialquilaminoalquilbifenilo sustituidos, procedimiento para su preparacion, medicamentos que contienen estos compuestos y el uso de estoscompuestos para la preparacion de medicamentos.
CY1110600T1 (el) Αναλογα της βιταμινης d
DK166256C (da) Konfektionsforpakninger til laegemiddelkombinationer til indtagelse med tidsintervaller
UA70921C2 (uk) Похідні 2-(імінометил)амінофенілу, спосіб їх одержання (варіанти) та фармацевтична композиція, що містить ці сполуки
AR012504A1 (es) Utilizacion de derivados de tetrahidropiridina, para la preparacion de medicamentos para el tratamiento de las enfermedades que provocan unadesmielinizacion.
BR0014826A (pt) Imidazo-3-il-aminas bicìclicas, procedimento de sua preparação e medicamentos que as contêm
BRPI0507582A (pt) embalagens de lente de contato
ES2126114T3 (es) Composiciones liquidas estables de interferon gamma.
IL166483A0 (en) Pharmaceutical compositions containing ciclesonideand an antihistamine
AR019025A1 (es) Uso de eritropoyetina en bajas dosis para producir un preparado farmaceutico para el tratamiento de hemocromatosis, preparado farmaceutico combinadoutilizado segun dicho uso y envase farmaceutico unitario que contiene al referido preparado farmaceutico combinado
ES2172023T3 (es) Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
DK0577745T3 (da) Bis-naphtalimider indeholdende amid- og thioamid-forbindelsesstykker som anticancermidler.
ES2173556T3 (es) Nuevos compuestos heterociclicos, su procedimiento de preparacion y los compuestos farmaceuticos que los contienen.
EP0869786A4 (en) PHARMACEUTICAL COMPOUNDS

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application